For citations:

Kalinina A.A., Kazansky D.B., Khromykh L.M. Anti-tumor effects of recombinant human cyclophilin A combined with immune checkpoint inhibitors in the experimental model of melanoma B16 in vivo. Advances in Molecular Oncology. 2024;11(3):79-91. (In Russ.) https://doi.org/10.17650/2313-805X-2024-11-3-79-91